License to Kill – From Killer Experiments and Synthetic Lethality
The Maternal Embryonic Leucine zipper Kinase (MELK) is an interesting enzyme:In 2005, MELK was first implicated in cancer by finding elevated levels of MELK RNA expression in many human tumors (REF1). Since the initial article, another 32 articles have been published that specifically implicate MELK as …